Biogen (NASDAQ: BIIB) November weekly option implied volatility is at 31, December weekly is at 58, December is at 45; compared to its 52-week range of 29 to 97 into data will be peer reviewed and presented Nov. 29 at the Clinical Trials on Alzheimer's Congress.